NUDT1 and non-small cell lung carcinoma: In a separate study focusing on non-small cell lung cancer (NSCLC), it was discovered that MTH1 not only promotes the progression of NSCLC but also enhances activities in the MAPK pathway and PI3K/AKT in cancer cells.